查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球神经血管设备市场：到 2028 年的预测—按产品、应用、最终用户和地区分析
市场调查报告书
商品编码
1218889

全球神经血管设备市场：到 2028 年的预测—按产品、应用、最终用户和地区分析

Neurovascular Devices Market Forecasts to 2028 - Global Analysis By Product, Application, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2022 年全球神经血管器械市场规模将达到 27.6 亿美元，预计到 2028 年将达到 50.6 亿美元，预计将以 10.6 %的 CAGR 增长。

神经血管问题是用神经血管设备治疗的。 神经血管疾病是由大脑的血液和氧气供应不足或受限引起的，可导致严重残疾甚至死亡。 这些包括中风、脑动脉瘤、动静脉畸形和狭窄。 神经血管疾病的全球流行正在加速神经血管设备的市场。 神经学仪器通常用于诊断和治疗大脑和中枢神经系统疾病。 随着神经学技术的进步，对神经血管设备的需求也在增加。

根据脑动脉瘤基金会的数据，据信每年有 600 万美国人患上脑动脉瘤。 此外，这种疾病每年在全世界造成 500,000 人死亡。 这些趋势导致大量患者需要就医。

市场动态

促进因素

脑出血增加

由于城市化进程加快、缺乏锻炼和压力等各种原因，全球中风的发病率正在上升。 这些变化正在产生大量需要医疗护理的患者。 这一点，以及患者对神经血管疾病治疗和报销意识的提高，特别是在新兴市场，预计将在预测期内进一步加速神经血管设备市场的增长。 新兴国家的政府和非营利组织对向公众宣传神经血管疾病的不同形式和症状、紧急预防措施和可用的治疗方法表现出了积极的兴趣，这将有助于市场的发展。

抑制因素

严格的规定

限制神经血管设备全球市场的主要因素之一是神经血管手术和设备的高成本，尤其是在报销制度宽鬆的新兴国家。 此外，维护成本和其他间接成本增加了这些设备的总拥有成本，限制了它们的部署。 预算限制使得小型医院和独立的 ASC 难以购买昂贵且复杂的技术，这一问题在发展中国家更为突出。 在较贫穷的国家，由于费用高昂和报销环境薄弱，很少有患者能够获得神经科治疗。 因此，医疗机构不愿花钱购买新颖、尖端的技术解决方案，从而限制了神经血管设备的市场。

机会

神经血管内装置的保险范围

在发达国家，中风治疗的经济负担越来越重。 因此，这个国家对神经血管设备的接受度在很大程度上受到公共和私人健康保险覆盖面的影响。 在亚太地区的新兴国家，如中国和日本，政府和非政府组织正在采取措施完善和实施神经血管疾病治疗的保险覆盖政策。 预计这些因素将鼓励更多人寻求治疗并推动市场增长。

威胁

严格的规定

过去十年，Stryker 和 Medtronic Plc 等领先製造商已成功开发血管内神经治疗设备并将其商业化。 这些产品主要用于海外的神经血管手术。 然而，在成熟国家，主要产品製造商因过去三年实施的不利政府改革而承受的价格压力是影响全球神经产品开发管线的主要因素。

COVID-19 的影响

COVID-19 大流行对神经血管设备市场产生了负面影响，对每个行业的部门造成了干扰、限制、困难和调整。 同样，大流行也影响了神经血管设备行业。 例如，在外科手术过程中使用神经血管装置。 因此，神经血管市场受到全球限制获得 COVID-19 以外疾病医疗保健的负面影响。 此外，全球医务人员供应有限是对神经血管设备市场产生负面影响的另一个因素。 因此，上述所有影响都阻碍了市场的增长。

栓塞器械细分市场预计在预测期内将成为最大的细分市场

由于广泛的研发活动的增长、对微创手术的认识不断提高以及栓塞产品和技术的技术进步，栓塞器械领域预计将实现良好增长。 近年来，各种疾病的患者选择已转向微创治疗方法。 它也被认为比传统的开放手术更安全，因为恢復时间更短。 栓塞也是一种微创技术，用于阻止血液流向异常组织肿瘤。 由于患者对微创栓塞手术的偏好不断变化，市场正在扩大。 随着微创手术需求的增加，栓塞市场预计将促进神经血管设备市场的增长。

在预测期内，缺血性中风部分预计将见证最高的复合年增长率

在预测期内，缺血性中风部分预计将以最快的复合年增长率增长。 随着缺血性中风患病率的普遍增加以及治疗这种疾病的新技术的可用性，预计将推动用于介入神经病学的神经血管设备的市场扩张。 据美国疾病控制和预防中心称，大约 87% 的中风是由脑血流停滞引起的。 美国心臟协会还建议使用支架取出工具去除凝块，这样患者就不会遭受缺血性中风。 因此，随着缺血患者数量的增加，预计在预测期内对神经血管设备的需求将会增加。

市场份额最高的地区

由于患有神经血管疾病的老年人数量迅速增加，预计亚太地区在预测期内将占据最大的市场份额。 例如，亚太地区的老龄化人口正以前所未有的速度增长，预计到 2050 年该地区四分之一的人口将超过 60 岁。 这要归功于联合国人口基金。 此外，由于日本、中国和印度等多个国家的新兴市场，亚太地区的市场有望增长。 医疗保健基础设施的扩大和神经血管疾病患病率的上升，预计亚太地区的市场将出现大幅增长。

复合年增长率最高的地区

由于神经血管疾病发病率上升以及对微创手术的强劲需求，预计欧洲在预测期内的复合年增长率最高。 例如，美国疾病控制和预防中心估计，欧洲每年发生超过 795,000 例中风，约占所有中风的 87%。 此外，由于医疗成本上升以及德国、法国和意大利等国家广泛使用技术先进的系统，神经介入设备的使用预计在预测期内会增加，从而推动市场增长。

主要发展

2022 年 12 月，全球最大、最多元化的医疗保健产品公司强生公司今天宣布已完成对 Abiomed 的收购。 Abiomed 现在是强生公司的一部分，并将作为强生公司医疗技术部门的一个独立业务部门运营。

2022 年 12 月，强生旗下杨森製药公司公布了 DARZARLEX (daratumumab) 联合来那度胺和地塞米松 (D-Rd) 的 3 期 MAIA 研究的新分析结果，无进展生存期 (PFS)、最小残留介绍了中位随访时疾病 (MRD) 阴性和总体缓解率 (ORR)。

2022 年 12 月，强生公司公布了在研、即用型双特异性 T 细胞接合抗体 tarquetamab 的 1/2 期 MonumentTAL-1 研究的最新结果。 Talquetamab 靶向多发性骨髓瘤细胞的新靶点 GPRC5D 和 T 细胞上的 CD3，推动人体免疫系统来对抗这种血癌。

2022 年 12 月，美敦力 (Medtronic) 宣布在美国进行 HUGO(TM) 机器人手术系统 HUGO(TM) RAS 系统临床试验的首位患者招募根治性膀胱切除术和肾切除术（部分或根治性）手术。

本报告的内容

  • 区域和国家级细分市场的市场份额评估
  • 向新进入者提出战略建议
  • 2020、2021、2022、2025 和 2028 年的综合市场数据
  • 涵盖市场趋势（市场促进因素、促进因素、机遇、威胁、挑战、投资机会、建议）
  • 根据市场预测在关键业务领域提出战略建议
  • 竞争格局映射主要共同趋势
  • 公司简介，包括详细的战略、财务状况和近期发展
  • 映射最新技术进步的供应链趋势

免费定制服务

订阅此报告的客户将免费获得以下自定义选项之一

  • 公司简介
    • 其他市场参与者的综合概况（最多 3 家公司）
    • 主要参与者的 SWOT 分析（最多 3 家公司）
  • 区域细分
    • 根据客户要求对主要国家/地区的市场进行估算、预测和復合年增长率（注意：基于可行性检查）
  • 竞争基准
    • 根据产品组合、地域分布和战略联盟对主要参与者进行基准测试

内容

第 1 章内容提要

第 2 章前言

  • 概览
  • 利益相关者
  • 调查范围
  • 调查方法
    • 数据挖掘
    • 数据分析
    • 数据验证
    • 研究方法
  • 调查来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 假设

第 3 章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第 4 章波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第 5 章全球神经血管设备市场：按产品分类

  • 脑球囊血管成形术
  • 动脉瘤捲绕术
  • 神经取栓装置
  • 支持的设备
  • 支架放置系统
  • 栓塞装置
  • 其他产品

第 6 章全球神经血管设备市场：按应用

  • 缺血性中风
  • 脑动脉瘤
  • 颈动脉狭窄
  • 动静脉畸形和瘘管

第 7 章全球神经血管设备市场：按最终用户分类

  • 医院
  • 专科诊所
  • 门诊中心
  • 其他最终用户

第 8 章全球神经血管设备市场：按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 意大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 新西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 卡塔尔
    • 南非
    • 其他中东地区

第 9 章主要进展

  • 合同、伙伴关係、协作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第 10 章公司简介

  • Johnson & Johnson Services, Inc.
  • Medtronic
  • Penumbra, Inc.
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • Shape Memory Medical
  • Imperative Care
  • Integer Holdings Corporation
  • ASAHI INTECC CO., LTD.
  • Stryker
  • Microvention Inc
  • Codman Neuro
  • Merit Medical Systems
  • W.L.Gore & Associates, Inc
  • Acandis GmbH
Product Code: SMRC22425

According to Stratistics MRC, the Global Neurovascular Devices Market is accounted for $2.76 billion in 2022 and is expected to reach $5.06 billion by 2028 growing at a CAGR of 10.6% during the forecast period. Neurovascular problems are treated with neurovascular devices. The neurovascular illnesses might cause the patient to experience significant disability or perhaps pass away because they are brought on by inadequate or constrained blood and oxygen supply to the brain. Strokes, brain aneurysms, arteriovenous malformations, and stenosis can result from this. The global prevalence of neurovascular illnesses is driving acceleration in the market for neurovascular devices. In order to diagnose and treat disorders of the brain and central nervous system, neurological gadgets are routinely utilised. Because of advances in technology in neurology, there is a growing demand for neurovascular devices.

According to the Brain Aneurysm Foundation, 6 million Americans are thought to experience brain aneurysms annually. Additionally, every year, the illness kills half a million people worldwide. These trends are creating a sizable patient population that needs medical attention.

Market Dynamics:

Driver:

Rise in the number of strokes

The incidence of strokes worldwide has been rising as a result of a number of causes, including growing urbanisation, an inactive lifestyle and stress. Such changes are creating a huge patient population that needs medical attention. This is expected to further accelerate the growth of the neurovascular devices market during the projected period, along with rising patient awareness regarding the accessibility of treatment and reimbursement for neurovascular illnesses, particularly in emerging nations. Governments and non-profit organizations from developing nations are actively interested in educating the general public about the different forms of neurovascular illnesses, their symptoms, the precautions to take in an emergency, and the available treatments which are accelerating the market growth.

Restraint:

Strict regulations

One of the main factors limiting the global market for neurovascular devices is the high cost of neurovascular surgical procedures and equipment, particularly in developing nations with lax reimbursement systems. Additionally, the total cost of ownership of these devices rises due to maintenance costs and other related indirect costs, which restricts their adoption. Budgetary restrictions make it more difficult for small hospitals and independent ASCs to purchase expensive and complex technologies this problem is more pronounced in developing nations. Only a very small number of patients in impoverished nations can afford neurological treatment due to exorbitant costs and a weak reimbursement environment. As a result, healthcare facilities are hesitant to spend money on novel or cutting-edge technical solutions, which restricts the market for neurovascular devices.

Opportunity:

Insurance Coverage for Neurovascular Devices

Patients have a heavy financial burden for stroke treatment in developed countries. Therefore, the acceptance of neurovascular devices in this country has been greatly influenced by the availability of insurance coverage through public and private health insurance. Government and non-government groups have taken steps to improve and execute insurance coverage policies for the treatment of neurovascular illnesses in rising Asia-Pacific nations like China and Japan. It is anticipated that this factor would result in more people receiving therapy encouraging the market growth.

Threat:

Strict regulations

Various major producers of neurovascular devices, including Stryker and Medtronic Plc, have had success in the previous ten years with the creation and subsequent commercialization of their individual products. These goods were primarily made for usage abroad during neurovascular operations. However, in mature countries, pricing pressure experienced by the major product makers as a result of unfavourable government reforms implemented in the previous three years is the principal factor affecting the development pipeline for worldwide neurology goods.

COVID-19 Impact

The COVID-19 pandemic has had a negative impact on the neurovascular devices market which caused disruption, constraints, difficulties, and adjustments in every industry's sector. Similar to this, the pandemic also had an effect on the neurovascular devices industry. Neurovascular devices, for instance, are employed during surgical procedures. As a result, the neurovascular market has been negatively impacted by the limited accessibility of medical care for disorders other than COVID-19 globally. Another component that has an adverse impact on the market for neurovascular devices is the restricted supply of healthcare workers globally. Thus all the above impacts have hampered the market growth.

The embolization devices segment is expected to be the largest during the forecast period

The embolization devices segment is estimated to have a lucrative growth, due to the extensive R&D activity growth, increased awareness in less invasive procedures, and technological advancements in embolization products and techniques. Patients' choices for various diseases are shifting in recent years to choose minimally invasive therapies. Moreover, since the recovery time is less than with conventional open procedures, it is safer. Embolization is another minimally invasive technique used to stop the blood flow to abnormal tissue tumours. The market is growing as a result of patients' changing preferences toward less invasive embolization. The market for embolization is predicted to grow as demand for minimally invasive procedures increases in turn helps in growth of the neurovascular devices market.

The ischemic stroke segment is expected to have the highest CAGR during the forecast period

The ischemic stroke segment is anticipated to witness the fastest CAGR growth during the forecast period; due to the widespread increase in the prevalence of ischemic stroke and the accessibility of novel technologies for the condition's treatment and aspects that are expected to drive the market expansion for neurovascular devices used in interventional neurology. About 87% of strokes, according to the Centers for Disease Control and Prevention, are brought on by a blockage in cerebral blood flow. The American Heart Association also suggests using stent retrieval tools to remove blood clots from patients to help patients avoid having an ischemic stroke. Thus, it is projected that during the forecast period, demand for neurovascular devices will increase as ischemia cases rise.

Region with highest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the number of geriatrics with neurovascular diseases is growing quickly. For instance, the Asia Pacific region's geriatric population is growing at an unprecedented rate, and it is predicted that by 2050, one in four persons in this region would be over 60. This is according to the United Nations Population Fund. Additionally, the Asia Pacific market is anticipated to increase as a result of the emerging markets in various nations, including Japan, China, and India. Due to the expanding health care infrastructure and rising prevalence of neurovascular diseases, Asia pacific region is anticipated to show considerable market growth.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to the rising incidence of neurovascular disorders and the strong demand for minimally invasive procedures. For instance, the Centers for Disease Control and Prevention estimate that more than 795,000 strokes, or approximately 87% of all strokes, occur in the Europe each year. In addition, it is anticipated that the use of neuro interventional devices would increase over the course of the projection period due to rising healthcare costs and the widespread use of technologically sophisticated systems in nations like Germany, France and Italy regions are propelling the market growth.

Key players in the market

Some of the key players profiled in the Neurovascular Devices Market include Johnson & Johnson Services, Inc., Medtronic, Penumbra, Inc, Terumo Corporation, MicroPort Scientific Corporation, Shape Memory Medical, Imperative Care, Integer Holdings Corporation, ASAHI INTECC CO., LTD, Stryker, Microvention Inc, Codman Neuro, Merit Medical Systems, W.L.Gore & Associates, Inc and Acandis GmbH.

Key Developments:

In Dec 2022, Johnson & Johnson the world's largest, most diversified healthcare products company, today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now part of Johnson & Johnson and will operate as a standalone business within Johnson & Johnson's MedTech segment.

In Dec 2022, The Janssen Pharmaceutical Companies of Johnson & Johnson announced new analyses from the Phase 3 MAIA study of DARZALEX® (daratumumab) in combination with lenalidomide and dexamethasone (D-Rd), evaluating progression-free survival (PFS), minimal residual disease (MRD) negativity and overall response rate (ORR) at a median follow up.

In Dec 2022, the Johnson & Johnson announced updated results from the Phase 1/2 MonumenTAL-1 study of talquetamab, an investigational, off-the-shelf (ready to use), bispecific T-cell engager antibody. Talquetamab targets both GPRC5D, a novel target on multiple myeloma cells, and CD3 on T cells, activating the body's immune system to fight this blood cancer.

In Dec 2022, Medtronic announces first patient enrolled in U.S. clinical trial for Hugo™ robotic-assisted surgery system the Hugo™ RAS system is intended to be used in this study for urologic surgical procedures including radical prostatectomy, radical cystectomy, and nephrectomy (partial or radical) procedures at sites in the U.S.

Products Covered:

  • Cerebral Balloon Angioplasty
  • Aneurysm Coiling
  • Neurothrombectomy Devices
  • Support Devices
  • Stenting Systems
  • Embolization Devices
  • Other Products

Applications Covered:

  • Ischemic Stroke
  • Cerebral Aneuryms
  • Carotid Artery Stenosis
  • Arteriovenous Malformations & Fistulas

End Users Covered:

  • Hospitals
  • Speciality Clinics
  • Ambulatory Care Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neurovascular Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Cerebral Balloon Angioplasty
  • 5.3 Aneurysm Coiling
  • 5.4 Neurothrombectomy Devices
  • 5.5 Support Devices
  • 5.6 Stenting Systems
  • 5.7 Embolization Devices
  • 5.8 Other Products

6 Global Neurovascular Devices Market, By Application

  • 6.1 Introduction
  • 6.2 Ischemic Stroke
  • 6.3 Cerebral Aneuryms
  • 6.4 Carotid Artery Stenosis
  • 6.5 Arteriovenous Malformations & Fistulas

7 Global Neurovascular Devices Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Speciality Clinics
  • 7.4 Ambulatory Care Centers
  • 7.5 Other End Users

8 Global Neurovascular Devices Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Johnson & Johnson Services, Inc.
  • 10.2 Medtronic
  • 10.3 Penumbra, Inc.
  • 10.4 Terumo Corporation
  • 10.5 MicroPort Scientific Corporation
  • 10.6 Shape Memory Medical
  • 10.7 Imperative Care
  • 10.8 Integer Holdings Corporation
  • 10.9 ASAHI INTECC CO., LTD.
  • 10.10 Stryker
  • 10.11 Microvention Inc
  • 10.12 Codman Neuro
  • 10.13 Merit Medical Systems
  • 10.14 W.L.Gore & Associates, Inc
  • 10.15 Acandis GmbH

List of Tables

  • 1 Global Neurovascular Devices Market Outlook, By Region (2020-2028) ($MN)
  • 2 Global Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
  • 3 Global Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
  • 4 Global Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
  • 5 Global Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
  • 6 Global Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
  • 7 Global Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
  • 8 Global Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
  • 9 Global Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
  • 10 Global Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
  • 11 Global Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
  • 12 Global Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
  • 13 Global Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
  • 14 Global Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
  • 15 Global Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
  • 16 Global Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
  • 17 Global Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
  • 18 Global Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
  • 19 Global Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)
  • 20 North America Neurovascular Devices Market Outlook, By Country (2020-2028) ($MN)
  • 21 North America Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
  • 22 North America Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
  • 23 North America Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
  • 24 North America Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
  • 25 North America Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
  • 26 North America Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
  • 27 North America Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
  • 28 North America Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
  • 29 North America Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
  • 30 North America Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
  • 31 North America Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
  • 32 North America Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
  • 33 North America Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
  • 34 North America Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
  • 35 North America Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
  • 36 North America Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
  • 37 North America Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
  • 38 North America Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)
  • 39 Europe Neurovascular Devices Market Outlook, By Country (2020-2028) ($MN)
  • 40 Europe Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
  • 41 Europe Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
  • 42 Europe Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
  • 43 Europe Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
  • 44 Europe Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
  • 45 Europe Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
  • 46 Europe Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
  • 47 Europe Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
  • 48 Europe Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
  • 49 Europe Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
  • 50 Europe Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
  • 51 Europe Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
  • 52 Europe Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
  • 53 Europe Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
  • 54 Europe Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
  • 55 Europe Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
  • 56 Europe Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
  • 57 Europe Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)
  • 58 Asia Pacific Neurovascular Devices Market Outlook, By Country (2020-2028) ($MN)
  • 59 Asia Pacific Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
  • 60 Asia Pacific Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
  • 61 Asia Pacific Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
  • 62 Asia Pacific Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
  • 63 Asia Pacific Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
  • 64 Asia Pacific Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
  • 65 Asia Pacific Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
  • 66 Asia Pacific Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
  • 67 Asia Pacific Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
  • 68 Asia Pacific Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
  • 69 Asia Pacific Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
  • 70 Asia Pacific Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
  • 71 Asia Pacific Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
  • 72 Asia Pacific Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
  • 73 Asia Pacific Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
  • 74 Asia Pacific Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
  • 75 Asia Pacific Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
  • 76 Asia Pacific Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)
  • 77 South America Neurovascular Devices Market Outlook, By Country (2020-2028) ($MN)
  • 78 South America Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
  • 79 South America Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
  • 80 South America Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
  • 81 South America Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
  • 82 South America Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
  • 83 South America Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
  • 84 South America Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
  • 85 South America Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
  • 86 South America Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
  • 87 South America Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
  • 88 South America Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
  • 89 South America Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
  • 90 South America Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
  • 91 South America Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
  • 92 South America Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
  • 93 South America Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
  • 94 South America Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
  • 95 South America Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)
  • 96 Middle East & Africa Neurovascular Devices Market Outlook, By Country (2020-2028) ($MN)
  • 97 Middle East & Africa Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
  • 98 Middle East & Africa Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
  • 99 Middle East & Africa Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
  • 100 Middle East & Africa Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
  • 101 Middle East & Africa Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
  • 102 Middle East & Africa Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
  • 103 Middle East & Africa Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
  • 104 Middle East & Africa Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
  • 105 Middle East & Africa Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
  • 106 Middle East & Africa Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
  • 107 Middle East & Africa Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
  • 108 Middle East & Africa Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
  • 109 Middle East & Africa Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
  • 110 Middle East & Africa Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
  • 111 Middle East & Africa Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
  • 112 Middle East & Africa Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
  • 113 Middle East & Africa Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
  • 114 Middle East & Africa Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)